 | • レポートコード：20QY06-02574 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ナノドラッグのグローバル市場について種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルション、ナノサスペンション）、用途別（癌および腫瘍、自己免疫疾患）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ナノドラッグ市場の概要 ・世界の主要地域別ナノドラッグ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のナノドラッグ市場規模2015-2026：種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルション、ナノサスペンション） ・世界のナノドラッグ市場規模2015-2026：用途別（癌および腫瘍、自己免疫疾患） ・ナノドラッグの北米市場規模2015-2020 ・ナノドラッグのヨーロッパ市場規模2015-2020 ・ナノドラッグの中国市場規模2015-2020 ・ナノドラッグの日本市場規模2015-2020 ・ナノドラッグの東南アジア市場規模2015-2020 ・ナノドラッグのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy） ・ナノドラッグの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナノドラッグの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Nano-drug Market
The global Nano-drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Nano-drug Scope and Market Size
The global Nano-drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nano-drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Nano-drug market is segmented into
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Segment by Application, the Nano-drug market is segmented into
Cancer and Tumors
Autoimmune Disorders
The Nano-drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Nano-drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nano-drug Market Share Analysis
Nano-drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nano-drug business, the date to enter into the Nano-drug market, Nano-drug product introduction, recent developments, etc.
The major vendors covered:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Table of Contents
1 Nano-drug Market Overview
1.1 Nano-drug Product Scope
1.2 Nano-drug Segment by Type
1.2.1 Global Nano-drug Sales by Type (2020-2026)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid lipid Nanoparticles
1.2.5 Microemulsion and Nanoemulsion
1.2.6 Nanosuspension
1.3 Nano-drug Segment by Application
1.3.1 Global Nano-drug Sales Comparison by Application (2020-2026)
1.3.2 Cancer and Tumors
1.3.3 Autoimmune Disorders
1.4 Nano-drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Nano-drug Sales Growth Rate (2015-2026)
1.4.2 Global Nano-drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Nano-drug Price Trends (2015-2026)
2 Nano-drug Estimate and Forecast by Region
2.1 Global Nano-drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Nano-drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Nano-drug Sales Market Share by Region (2015-2020)
2.2.2 Global Nano-drug Revenue Market Share by Region (2015-2020)
2.3 Global Nano-drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Nano-drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Nano-drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Nano-drug Estimates and Projections (2015-2026)
2.4.2 Europe Nano-drug Estimates and Projections (2015-2026)
2.4.3 China Nano-drug Estimates and Projections (2015-2026)
2.4.4 Japan Nano-drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Nano-drug Estimates and Projections (2015-2026)
2.4.6 India Nano-drug Estimates and Projections (2015-2026)
3 Global Nano-drug Competition Landscape by Players
3.1 Global Top Nano-drug Players by Sales (2015-2020)
3.2 Global Top Nano-drug Players by Revenue (2015-2020)
3.3 Global Nano-drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano-drug as of 2019)
3.4 Global Nano-drug Average Price by Company (2015-2020)
3.5 Manufacturers Nano-drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Nano-drug Players (Opinion Leaders)
4 Global Nano-drug Market Size by Type
4.1 Global Nano-drug Historic Market Review by Type (2015-2020)
4.1.1 Global Nano-drug Sales Market Share by Type (2015-2020)
4.1.2 Global Nano-drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Nano-drug Price by Type (2014-2020)
4.2 Global Nano-drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Nano-drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nano-drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Nano-drug Price Forecast by Type (2021-2026)
5 Global Nano-drug Market Size by Application
5.1 Global Nano-drug Historic Market Review by Application (2015-2020)
5.1.1 Global Nano-drug Sales Market Share by Application (2015-2020)
5.1.2 Global Nano-drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Nano-drug Price by Application (2015-2020)
5.2 Global Nano-drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Nano-drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nano-drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nano-drug Price Forecast by Application (2021-2026)
3 North America Nano-drug Market Facts & Figures
3.2 North America Nano-drug Sales Market Share by Company (2015-2020)
3.3 North America Nano-drug Sales Market Share by Type (2015-2020)
3.4 North America Nano-drug Sales Market Share by Application (2015-2020)
4 Europe Nano-drug Market Facts & Figures
4.2 Europe Nano-drug Sales Market Share by Company (2015-2020)
4.3 Europe Nano-drug Sales Market Share by Type (2015-2020)
4.4 Europe Nano-drug Sales Market Share by Application (2015-2020)
5 China Nano-drug Market Facts & Figures
5.2 China Nano-drug Sales Market Share by Company (2015-2020)
5.3 China Nano-drug Sales Market Share by Type (2015-2020)
5.4 China Nano-drug Sales Market Share by Application (2015-2020)
6 Japan Nano-drug Market Facts & Figures
6.2 Japan Nano-drug Sales Market Share by Company (2015-2020)
6.3 Japan Nano-drug Sales Market Share by Type (2015-2020)
6.4 Japan Nano-drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Nano-drug Market Facts & Figures
7.2 Southeast Asia Nano-drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Nano-drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Nano-drug Sales Market Share by Application (2015-2020)
8 India Nano-drug Market Facts & Figures
8.2 India Nano-drug Sales Market Share by Company (2015-2020)
8.3 India Nano-drug Sales Market Share by Type (2015-2020)
8.4 India Nano-drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Nano-drug Business
12.1 Merck
12.1.1 Merck Nano-drug Corporation Information
12.1.2 Merck Nano-drug Business Overview and Total Revenue
12.1.3 Merck Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Nano-drug Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Nano-drug Corporation Information
12.2.2 Pfizer Nano-drug Business Overview and Total Revenue
12.2.3 Pfizer Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Nano-drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Nano-drug Corporation Information
12.3.2 Novartis Nano-drug Business Overview and Total Revenue
12.3.3 Novartis Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Nano-drug Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Nano-drug Corporation Information
12.4.2 Abbott Nano-drug Business Overview and Total Revenue
12.4.3 Abbott Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Nano-drug Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Nano-drug Corporation Information
12.5.2 GlaxoSmithKline Nano-drug Business Overview and Total Revenue
12.5.3 GlaxoSmithKline Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Nano-drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Nano-drug Corporation Information
12.6.2 Roche Nano-drug Business Overview and Total Revenue
12.6.3 Roche Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Nano-drug Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Nano-drug Corporation Information
12.7.2 Sanofi Nano-drug Business Overview and Total Revenue
12.7.3 Sanofi Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Nano-drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Nano-drug Corporation Information
12.8.2 Eli Lilly Nano-drug Business Overview and Total Revenue
12.8.3 Eli Lilly Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nano-drug Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Nano-drug Corporation Information
12.9.2 Astrazeneca Nano-drug Business Overview and Total Revenue
12.9.3 Astrazeneca Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Nano-drug Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Nano-drug Corporation Information
12.10.2 Johnson & Johnson Nano-drug Business Overview and Total Revenue
12.10.3 Johnson & Johnson Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Nano-drug Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Celgene
12.11.1 Celgene Nano-drug Corporation Information
12.11.2 Celgene Nano-drug Business Overview and Total Revenue
12.11.3 Celgene Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Celgene Nano-drug Products Offered
12.11.5 Celgene Recent Development
12.12 Novavax
12.12.1 Novavax Nano-drug Corporation Information
12.12.2 Novavax Nano-drug Business Overview and Total Revenue
12.12.3 Novavax Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novavax Nano-drug Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Nano-drug Corporation Information
12.13.2 Stryker Nano-drug Business Overview and Total Revenue
12.13.3 Stryker Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Stryker Nano-drug Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Nano-drug Corporation Information
12.14.2 Gilead Sciences Nano-drug Business Overview and Total Revenue
12.14.3 Gilead Sciences Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Nano-drug Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Nano-drug Corporation Information
12.15.2 OSI Pharmaceuticals Nano-drug Business Overview and Total Revenue
12.15.3 OSI Pharmaceuticals Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 OSI Pharmaceuticals Nano-drug Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Nano-drug Corporation Information
12.16.2 Kadmon Pharmaceuticals Nano-drug Business Overview and Total Revenue
12.16.3 Kadmon Pharmaceuticals Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kadmon Pharmaceuticals Nano-drug Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Nano-drug Corporation Information
12.17.2 Samyang Biopharm Nano-drug Business Overview and Total Revenue
12.17.3 Samyang Biopharm Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Samyang Biopharm Nano-drug Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Nano-drug Corporation Information
12.18.2 Mitsubishi Pharma Nano-drug Business Overview and Total Revenue
12.18.3 Mitsubishi Pharma Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mitsubishi Pharma Nano-drug Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Nano-drug Corporation Information
12.19.2 Kaken Pharmaceutical Nano-drug Business Overview and Total Revenue
12.19.3 Kaken Pharmaceutical Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kaken Pharmaceutical Nano-drug Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Nano-drug Corporation Information
12.20.2 Selecta Biosciences Nano-drug Business Overview and Total Revenue
12.20.3 Selecta Biosciences Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Selecta Biosciences Nano-drug Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Nano-drug Corporation Information
12.21.2 Par Pharmaceutical Nano-drug Business Overview and Total Revenue
12.21.3 Par Pharmaceutical Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Par Pharmaceutical Nano-drug Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Nano-drug Corporation Information
12.22.2 Cerulean Pharma Nano-drug Business Overview and Total Revenue
12.22.3 Cerulean Pharma Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cerulean Pharma Nano-drug Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Nano-drug Corporation Information
12.23.2 Navidea Biopharmaceuticals Nano-drug Business Overview and Total Revenue
12.23.3 Navidea Biopharmaceuticals Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Navidea Biopharmaceuticals Nano-drug Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Nano-drug Corporation Information
12.24.2 Lummy Nano-drug Business Overview and Total Revenue
12.24.3 Lummy Nano-drug Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lummy Nano-drug Products Offered
12.24.5 Lummy Recent Development
13 Nano-drug Manufacturing Cost Analysis
13.1 Nano-drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nano-drug
13.4 Nano-drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nano-drug Distributors List
14.3 Nano-drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nano-drug Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Nano-drug Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market Nano-drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Nano-drug Sales (K Doses) by Region (2015-2020)
Table 5. Global Nano-drug Sales Market Share by Region (2015-2020)
Table 6. Global Nano-drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Nano-drug Revenue Share by Region (2015-2020)
Table 8. Global Nano-drug Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Nano-drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Nano-drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Nano-drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Nano-drug (K Doses) of Key Companies (2015-2020)
Table 13. Global Nano-drug Sales Share by Company (2015-2020)
Table 14. Global Nano-drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Nano-drug Revenue Share by Company (2015-2020)
Table 16. Global Nano-drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano-drug as of 2019)
Table 17. Global Nano-drug Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Nano-drug Manufacturing Sites and Area Served
Table 19. Manufacturers Nano-drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Nano-drug Players
Table 22. Global Nano-drug Sales (K Doses) by Type (2015-2020)
Table 23. Global Nano-drug Sales Share by Type (2015-2020)
Table 24. Global Nano-drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Nano-drug Price (K Doses) by Type (2015-2020)
Table 26. Global Nano-drug Sales Share by Type (2021-2026)
Table 27. Global Nano-drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Nano-drug Revenue Share by Type (2021-2026)
Table 29. Global Nano-drug Price (K Doses) by Type (2021-2026)
Table 30. Global Nano-drug Sales (K Doses) by Application (2015-2020)
Table 31. Global Nano-drug Sales Share by Application (2015-2020)
Table 32. Global Nano-drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Nano-drug Price (K Doses) by Application (2015-2020)
Table 34. Global Nano-drug Sales (K Doses) by Application (2021-2026)
Table 35. Global Nano-drug Sales Share by Application (2021-2026)
Table 36. Global Nano-drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Nano-drug Revenue Share by Application (2021-2026)
Table 38. Global Nano-drug Price (K Doses) by Application (2021-2026)
Table 39. United States Nano-drug Sales (K Doses) by Company (2015-2020)
Table 40. United States Nano-drug Sales Market Share by Company (2015-2020)
Table 41. United States Nano-drug Sales (K Doses) by Type (2015-2020)
Table 42. United States Nano-drug Sales Market Share by Type (2015-2020)
Table 43. United States Nano-drug Sales (K Doses) by Application (2015-2020)
Table 44. United States Nano-drug Sales Market Share by Application (2015-2020)
Table 45. Europe Nano-drug Sales (K Doses) by Company (2015-2020)
Table 46. Europe Nano-drug Sales Market Share by Company (2015-2020)
Table 47. Europe Nano-drug Sales (K Doses) by Type (2015-2020)
Table 48. Europe Nano-drug Sales Market Share by Type (2015-2020)
Table 49. Europe Nano-drug Sales (K Doses) by Application (2015-2020)
Table 50. Europe Nano-drug Sales Market Share by Type (2015-2020)
Table 51. China Nano-drug Sales (K Doses) by Company (2015-2020)
Table 52. China Nano-drug Sales Market Share by Company (2015-2020)
Table 53. China Nano-drug Sales (K Doses) by Type (2015-2020)
Table 54. China Nano-drug Sales Market Share by Type (2015-2020)
Table 55. China Nano-drug Sales (K Doses) by Application (2015-2020)
Table 56. China Nano-drug Sales Market Share by Application (2015-2020)
Table 57. Japan Nano-drug Sales (K Doses) by Company (2015-2020)
Table 58. Japan Nano-drug Sales Market Share by Company (2015-2020)
Table 59. Japan Nano-drug Sales (K Doses) by Type (2015-2020)
Table 60. Japan Nano-drug Sales Market Share by Type (2015-2020)
Table 61. Japan Nano-drug Sales (K Doses) by Application (2015-2020)
Table 62. Japan Nano-drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Nano-drug Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Nano-drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Nano-drug Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Nano-drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Nano-drug Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Nano-drug Sales Market Share by Application (2015-2020)
Table 69. India Nano-drug Sales (K Doses) by Company (2015-2020)
Table 70. India Nano-drug Sales Market Share by Company (2015-2020)
Table 71. India Nano-drug Sales (K Doses) by Type (2015-2020)
Table 72. India Nano-drug Sales Market Share by Type (2015-2020)
Table 73. India Nano-drug Sales (K Doses) by Application (2015-2020)
Table 74. India Nano-drug Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Merck Nano-drug Product
Table 79. Merck Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Pfizer Nano-drug Product
Table 84. Pfizer Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Novartis Nano-drug Product
Table 89. Novartis Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Abbott Nano-drug Product
Table 94. Abbott Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Nano-drug Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Roche Nano-drug Product
Table 104. Roche Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Sanofi Nano-drug Product
Table 109. Sanofi Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Eli Lilly Description and Business Overview
Table 113. Eli Lilly Nano-drug Product
Table 114. Eli Lilly Recent Development
Table 115. Astrazeneca Corporation Information
Table 116. Astrazeneca Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Astrazeneca Description and Business Overview
Table 118. Astrazeneca Nano-drug Product
Table 119. Astrazeneca Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Johnson & Johnson Nano-drug Product
Table 124. Johnson & Johnson Recent Development
Table 125. Celgene Corporation Information
Table 126. Celgene Description and Business Overview
Table 127. Celgene Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Celgene Nano-drug Product
Table 129. Celgene Recent Development
Table 130. Novavax Corporation Information
Table 131. Novavax Description and Business Overview
Table 132. Novavax Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Novavax Nano-drug Product
Table 134. Novavax Recent Development
Table 135. Stryker Corporation Information
Table 136. Stryker Description and Business Overview
Table 137. Stryker Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Stryker Nano-drug Product
Table 139. Stryker Recent Development
Table 140. Gilead Sciences Corporation Information
Table 141. Gilead Sciences Description and Business Overview
Table 142. Gilead Sciences Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Gilead Sciences Nano-drug Product
Table 144. Gilead Sciences Recent Development
Table 145. OSI Pharmaceuticals Corporation Information
Table 146. OSI Pharmaceuticals Description and Business Overview
Table 147. OSI Pharmaceuticals Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. OSI Pharmaceuticals Nano-drug Product
Table 149. OSI Pharmaceuticals Recent Development
Table 150. Kadmon Pharmaceuticals Corporation Information
Table 151. Kadmon Pharmaceuticals Description and Business Overview
Table 152. Kadmon Pharmaceuticals Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Kadmon Pharmaceuticals Nano-drug Product
Table 154. Kadmon Pharmaceuticals Recent Development
Table 155. Samyang Biopharm Corporation Information
Table 156. Samyang Biopharm Description and Business Overview
Table 157. Samyang Biopharm Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Samyang Biopharm Nano-drug Product
Table 159. Samyang Biopharm Recent Development
Table 160. Mitsubishi Pharma Corporation Information
Table 161. Mitsubishi Pharma Description and Business Overview
Table 162. Mitsubishi Pharma Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 163. Mitsubishi Pharma Nano-drug Product
Table 164. Mitsubishi Pharma Recent Development
Table 165. Kaken Pharmaceutical Corporation Information
Table 166. Kaken Pharmaceutical Description and Business Overview
Table 167. Kaken Pharmaceutical Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 168. Kaken Pharmaceutical Nano-drug Product
Table 169. Kaken Pharmaceutical Recent Development
Table 170. Selecta Biosciences Corporation Information
Table 171. Selecta Biosciences Description and Business Overview
Table 172. Selecta Biosciences Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 173. Selecta Biosciences Nano-drug Product
Table 174. Selecta Biosciences Recent Development
Table 175. Par Pharmaceutical Corporation Information
Table 176. Par Pharmaceutical Description and Business Overview
Table 177. Par Pharmaceutical Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 178. Par Pharmaceutical Nano-drug Product
Table 179. Par Pharmaceutical Recent Development
Table 180. Cerulean Pharma Corporation Information
Table 181. Cerulean Pharma Description and Business Overview
Table 182. Cerulean Pharma Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 183. Cerulean Pharma Nano-drug Product
Table 184. Cerulean Pharma Recent Development
Table 185. Navidea Biopharmaceuticals Corporation Information
Table 186. Navidea Biopharmaceuticals Description and Business Overview
Table 187. Navidea Biopharmaceuticals Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 188. Navidea Biopharmaceuticals Nano-drug Product
Table 189. Navidea Biopharmaceuticals Recent Development
Table 190. Lummy Corporation Information
Table 191. Lummy Description and Business Overview
Table 192. Lummy Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 193. Lummy Nano-drug Product
Table 194. Lummy Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Nano-drug Distributors List
Table 198. Nano-drug Customers List
Table 199. Market Key Trends
Table 200. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 201. Key Challenges
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Nano-drug Product Picture
Figure 2. Global Nano-drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nano-drug Market Share by Application in 2020 & 2026
Figure 6. Cancer and Tumors Examples
Figure 7. Autoimmune Disorders Examples
Figure 8. Global Nano-drug Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Nano-drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Nano-drug Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Nano-drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Nano-drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Nano-drug Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Nano-drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Nano-drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Nano-drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Nano-drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Nano-drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Nano-drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Nano-drug Players Market Share by Revenue in Nano-drug 2015 & 2019
Figure 26. Nano-drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Nano-drug Revenue Share by Type (2015-2020)
Figure 28. Global Nano-drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Nano-drug Revenue Share by Application (2015-2020)
Figure 30. Global Nano-drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Nano-drug Sales Market Share by Type in 2019
Figure 32. United States Nano-drug Sales Market Share by Type in 2019
Figure 33. Europe Nano-drug Sales Market Share by Company in 2019
Figure 34. Europe Nano-drug Sales Market Share by Type in 2019
Figure 35. Europe Nano-drug Sales Market Share by Application in 2019
Figure 36. China Nano-drug Sales Market Share by Company in 2019
Figure 37. China Nano-drug Sales Market Share by Type in 2019
Figure 38. China Nano-drug Sales Market Share by Application in 2019
Figure 39. Japan Nano-drug Sales Market Share by Company in 2019
Figure 40. Japan Nano-drug Sales Market Share by Type in 2019
Figure 41. Japan Nano-drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Nano-drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Nano-drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Nano-drug Sales Market Share by Application in 2019
Figure 45. India Nano-drug Sales Market Share by Company in 2019
Figure 46. India Nano-drug Sales Market Share by Type in 2019
Figure 47. India Nano-drug Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. OSI Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Kadmon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Samyang Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Mitsubishi Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Kaken Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Selecta Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Par Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Cerulean Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Navidea Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Lummy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Key Raw Materials Price Trend
Figure 73. Manufacturing Cost Structure of Nano-drug
Figure 74. Manufacturing Process Analysis of Nano-drug
Figure 75. Nano-drug Industrial Chain Analysis
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Porter's Five Forces Analysis
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
ナノ磁気デバイスの世界市場レポート2020 Market Analysis and Insights: Global Nano-magnetic Device Market The global Nano-magnetic Device market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nano-magnetic Device Scope and Market Size The global Nano-…- ナノ結晶セルロースの世界市場レポート2020 Market Analysis and Insights: Global Nano Crystalline Cellulose Market The global Nano Crystalline Cellulose market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nano Crystalline Cellulose Scope and Market Siz…
- ナノエレクトロニクスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nano Electronics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nano Electronics market repo…
- ナノ衛星の世界市場レポート2020 QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients. Report Overview: Nanosatellites are loosely defined as any…
- ナノセルロース繊維の世界市場レポート2020 Market Analysis and Insights: Global Nano-Cellulose Fibre Market The global Nano-Cellulose Fibre market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nano-Cellulose Fibre Scope and Market Size The global Nano-…